123 related articles for article (PubMed ID: 36404260)
21. [Geriatric assessment of patients with hematological neoplasms].
Hofer B; Nagl L; Hofer F; Stauder R
Z Gerontol Geriatr; 2017 Apr; 50(3):247-258. PubMed ID: 28364257
[TBL] [Abstract][Full Text] [Related]
22. Determining the optimal value of the Geriatric Nutritional Risk Index to screen older patients with malnutrition risk: A study at a university hospital in Japan.
Ishida Y; Maeda K; Nonogaki T; Shimizu A; Yamanaka Y; Matsuyama R; Kato R; Ueshima J; Mori N
Geriatr Gerontol Int; 2020 Sep; 20(9):811-816. PubMed ID: 33058420
[TBL] [Abstract][Full Text] [Related]
23. [Clinical Characteristics and Prognosis of Patients with Hematological Malignancies Superimposed with Solid Tumors].
Gui L; Zhang W; Shi JN; Zhang WJ; Yang ZN; Ma YC; Chen BA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):924-929. PubMed ID: 35680828
[TBL] [Abstract][Full Text] [Related]
24. Rearrangement of the myeloid/lymphoid leukemia gene in therapy-related myelodysplastic syndrome in patients previously treated with agents targeting DNA topoisomerase II.
Mosad E; Abdou M; Zaky AH
Oncology; 2012; 83(3):128-34. PubMed ID: 22814291
[TBL] [Abstract][Full Text] [Related]
25. Acute myeloid leukaemia following direct acting antiviral drugs in HCV-infected patients: A 10 years' retrospective single-center study.
Scheifer C; Luckina E; Lebrun-Vignes B; Diop AA; Damais-Thabut D; Roos-Weil D; Dechartres A; Lebray P
Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):102000. PubMed ID: 35933093
[TBL] [Abstract][Full Text] [Related]
26. Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies.
Hock BD; McKenzie JL; Patton NW; Drayson M; Taylor K; Wakeman C; Kantarjian H; Giles F; Albitar M
Cancer; 2006 May; 106(10):2148-57. PubMed ID: 16598754
[TBL] [Abstract][Full Text] [Related]
27. Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome.
Kong J; Gao MG; Qin YZ; Wang Y; Yan CH; Sun YQ; Chang YJ; Xu LP; Zhang XH; Liu KY; Huang XJ; Zhao XS
BMC Cancer; 2022 Jan; 22(1):11. PubMed ID: 34979982
[TBL] [Abstract][Full Text] [Related]
28. Updates on Hematologic Malignancies in the Older Adult: Focus on Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Huang LW; Wong SW; Andreadis C; Olin RL
Curr Oncol Rep; 2019 Mar; 21(4):35. PubMed ID: 30848394
[TBL] [Abstract][Full Text] [Related]
29. Prognostic role of controlling nutritional status score in hematological malignancies.
Zhang Y; Chen Q; Lu C; Yu L
Hematology; 2022 Dec; 27(1):653-658. PubMed ID: 35622088
[TBL] [Abstract][Full Text] [Related]
30. Cellular immunotherapy for refractory hematological malignancies.
Reagan JL; Fast LD; Safran H; Nevola M; Winer ES; Castillo JJ; Butera JN; Quesenberry MI; Young CT; Quesenberry PJ
J Transl Med; 2013 Jun; 11():150. PubMed ID: 23782682
[TBL] [Abstract][Full Text] [Related]
31. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
[TBL] [Abstract][Full Text] [Related]
32. Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility.
Gómez-Centurión I; Oarbeascoa G; García MC; López Fresneña MC; Martínez Carreño MJ; Escudero Vilaplana V; González-Haba E; Bailén R; Dorado N; Juárez LM; Rodríguez Macías G; Font López P; Encinas C; Bastos-Oreiro M; Anguita J; Sanjurjo M; Díez-Martin JL; Kwon M
Int J Hematol; 2022 Jan; 115(1):61-68. PubMed ID: 34553338
[TBL] [Abstract][Full Text] [Related]
33. A new tool for comprehensive geriatric assessment in elderly patients with acute myeloid leukemia: a pilot study from China.
Zhang CL; Feng R; Li JT; Wang T; Bai JF; Liu H
Chin Med J (Engl); 2020 Feb; 133(4):381-387. PubMed ID: 31934939
[TBL] [Abstract][Full Text] [Related]
34. The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma - a Swedish population-based study.
Mohammadi M; Cao Y; Glimelius I; Bottai M; Eloranta S; Smedby KE
BMC Cancer; 2015 Nov; 15():850. PubMed ID: 26537111
[TBL] [Abstract][Full Text] [Related]
35. Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome.
Deschler B; Ihorst G; Platzbecker U; Germing U; März E; de Figuerido M; Fritzsche K; Haas P; Salih HR; Giagounidis A; Selleslag D; Labar B; de Witte T; Wijermans P; Lübbert M
Haematologica; 2013 Feb; 98(2):208-16. PubMed ID: 22875615
[TBL] [Abstract][Full Text] [Related]
36. Utility of a chemotherapy toxicity prediction tool for older patients in a community setting.
Mariano C; Jamal R; Bains P; Hejazi S; Chao L; Wan J; Ho J
Curr Oncol; 2019 Aug; 26(4):234-239. PubMed ID: 31548802
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of chemical shift MRI for differentiating diffuse red bone marrow reconversion and hematological malignancies.
Akman B; Ata Korkmaz HA; Sarı A
Turk J Med Sci; 2019 Apr; 49(2):644-652. PubMed ID: 30889945
[TBL] [Abstract][Full Text] [Related]
38. [A 180-day mortality predictive score based on frailty syndrome in elderly patients with sepsis: a Logistic regression analysis model].
Dong J; Wang L; Xiong R; Liu X; Guo Z; Sun W; Chen R
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Mar; 33(3):257-262. PubMed ID: 33834964
[TBL] [Abstract][Full Text] [Related]
39. Incidence and risk of falls in patients treated for hematologic malignancies in the Intensive Hematology Unit.
Lorca LA; Sacomori C; Balagué-Ávila VP; Pino-Márquez LP; Quiroz-Vidal FA; Ortega L
Rev Lat Am Enfermagem; 2019 Apr; 27():e3145. PubMed ID: 31038638
[TBL] [Abstract][Full Text] [Related]
40. The feasibility of inpatient geriatric assessment for older adults receiving induction chemotherapy for acute myelogenous leukemia.
Klepin HD; Geiger AM; Tooze JA; Kritchevsky SB; Williamson JD; Ellis LR; Levitan D; Pardee TS; Isom S; Powell BL
J Am Geriatr Soc; 2011 Oct; 59(10):1837-46. PubMed ID: 22091497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
